Status:
COMPLETED
Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Cardiac Surgery
Central Venous Catheter Thrombosis
Eligibility:
All Genders
Up to 3 years
Phase:
NA
Brief Summary
Catheter-related thrombosis could impair blood flow in the vein, block the central venous catheter, induce catheter-related infection or venous thromboembolism in the deep veins or pulmonary vessels, ...
Detailed Description
Catheter-related thrombosis could impair blood flow in the vein, block the central venous catheter, induce catheter-related infection or venous thromboembolism in the deep veins or pulmonary vessels, ...
Eligibility Criteria
Inclusion
- less than 3 months of age at admission, post-cardiac surgery, with CVC indwelled
Exclusion
- parents' refusal, requiring postoperative anticoagulant administration (extracorporeal membrane oxygenation support, prosthetic devices), the contradiction to heparin (coagulopathy or hypercoagulable state, platelet level less than 50000/dL, clinically significant bleeding tendency, allergy to heparin)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04767113
Start Date
March 1 2021
End Date
August 31 2022
Last Update
September 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510080